| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Departments of Physiology and Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226
 |
ABSTRACT |
|---|
 Top
 Abstract
 Introduction
Materials and methods
Results
Discussion
References
|
|---|
This study
determined the levels of adenosine in the renal medullary interstitium
using microdialysis and fluorescence HPLC techniques and examined the
role of endogenous adenosine in the control of medullary blood flow and
sodium excretion by infusing the specific adenosine receptor
antagonists or agonists into the renal medulla of anesthetized
Sprague-Dawley rats. Renal cortical and medullary blood flows were
measured using laser-Doppler flowmetry. Analysis of microdialyzed
samples showed that the adenosine concentration in the renal medullary
interstitial dialysate averaged 212 ± 5.2 nM, which was
significantly higher than 55.6 ± 5.3 nM in the renal cortex
(n = 9). Renal medullary interstitial
infusion of a selective A1
antagonist, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX; 300 pmol · kg
1 · min1,
n = 8), did not alter renal blood
flows, but increased urine flow by 37% and sodium excretion by 42%.
In contrast, renal medullary infusion of the selective
A2 receptor blocker
3,7-dimethyl-1-propargylxanthine (DMPX; 150 pmol · kg1 · min1,
n = 9) decreased outer medullary blood
flow (OMBF) by 28%, inner medullary blood flows (IMBF) by 21%, and
sodium excretion by 35%. Renal medullary interstitial infusion of
adenosine produced a dose-dependent increase in OMBF, IMBF, urine flow,
and sodium excretion at doses from 3 to 300 pmol · kg1 · min1
(n = 7). These effects of adenosine
were markedly attenuated by the pretreatment of DMPX, but unaltered by
DPCPX. Infusion of a selective A3
receptor agonist,
N6-benzyl-5'-(N-ethylcarbonxamido)adenosine
(300 pmol · kg1 · min1,
n = 6) into the renal medulla had no
effect on medullary blood flows or renal function. Glomerular
filtration rate and arterial pressure were not changed by medullary
infusion of any drugs. Our results indicate that endogenous medullary
adenosine at physiological concentrations serves to dilate medullary
vessels via A2 receptors, resulting in a natriuretic response that overrides the tubular A1 receptor-mediated
antinatriuretic effects.
renal hemodynamics; renal medulla; laser-Doppler flowmetry
| |
INTRODUCTION |
|---|
|
Top
Abstract
Introduction
Materials and methods
Results
Discussion
References
|
|---|
ADENOSINE PLAYS an important role in cardiovascular homeostasis (6). Studies have indicated that adenosine is produced in response to tissue hypoxia and may serve as a negative feedback regulator to dilate vessels and to increase tissue blood perfusion, thereby returning the oxygen supply-to-demand ratio toward normal (6, 34). This adenosine feedback mechanism was first demonstrated to participate in the local regulation of coronary blood flow (5) and was extended to explain various types of active hyperemia in other tissues, including exercising skeletal muscle and the postprandial gastrointestinal circulation (14). In the kidney, however, adenosine-mediated metabolic regulation is more complex because of the marked regional heterogeneity of renal structure and function and the different effects of adenosine on pre- and postglomerular vessels (10, 21, 34). There is evidence, however, that this adenosine feedback regulatory process in the kidney may play an important role in the control of renal vascular tone and tubular transport. It has been proposed that adenosine may be produced by transporting epithelium and increase in response to metabolic demand in the kidney (8, 10, 11). Adenosine serves as a paracrine to decrease metabolic demand of the tubular cells through the contraction of cortical preglomerular arterioles, resulting in reduction of glomerular filtration rate (GFR), and to increase peritubular blood oxygen supply by dilating postglomerular vessels. These hemodynamic effects of adenosine appear to work together with its inhibitory action on tubular transport to adjust the metabolic supply and demand toward a level of transport activity appropriate for the oxygen and substrate availability of the tissue (34).
Recently, adenosine receptors have been cloned and designated A1, A2a, A2b, and A3 receptors (25). With the use of ligand binding, autoradiography, and measurement of adenylyl cyclase activity, two classical adenosine receptors, A1 and A2, have been shown in the renal cortex, outer medulla, and inner medulla (2, 36). These two subtypes of adenosine receptors have also been functionally localized to specific nephron segments, including glomeruli, thick ascending limb, and papillary collecting duct (2, 13). Recent studies using RT-PCR have detected the mRNA of these two subtypes of adenosine receptors in most segments along the nephron and in outer medullary descending vasa recta (15, 35). It is generally concluded that A1 and A2a receptors are widely distributed throughout the nephron and renal vasculature (21). It was demonstrated that stimulation of A1 receptors produced preglomerular vasoconstriction, activation of tubuloglomerular feedback response, and consequently reduction of GFR and sodium excretion (26, 34). Moreover, tubular A1 receptor activation may increase cortical and medullary tubular sodium reabsorption (18). In contrast, activation of A2 receptors, including A2a and A2b, dilates pre- and postglomerular vessels and inhibits tubular sodium reabsorption (18, 34). Therefore, A1 receptors are considered antidiuretic and antinatriuretic adenosine receptors, and A2 receptors are seen as diuretic and natriuretic adenosine receptors.
A3 receptors have been identified in different animal tissues, including rat and pig kidneys (7, 17). This novel adenosine receptor subtype is involved in the release of autocoids or paracrines, such as histamine, cytokines, leukotrienes, thromboxanes, and proteases, from mast cells and other interstitial cells in response to inflammatory or noninflammatory stimulations. Activation of A3 receptors was reported to contribute to the development of asthma, ischemic preconditioning (17), and adenosine-mediated vasoconstriction (30). It remains to be determined whether A3 receptors contribute to the control of medullary blood flow and tubular function.
The blood supply of the renal medulla is derived from the cortical efferent arterioles of the juxtamedullary glomeruli (16). Intrarenal administration of exogenous adenosine or adenosine A2 receptor agonists produced a marked increase in medullary blood flow and oxygenation (1, 10). However, the physiological role of endogenous medullary adenosine in the control of medullary circulation remains unknown. It is well known that there is a relatively hypoxic milieu in the outer medulla due to active transport of medullary thick ascending limb of Henle (TALH) and limited oxygen supply resulting from shunting of O2 in the outer medulla. On the presumption that adenosine feedback mechanism also occurs in the renal medulla, adenosine level in this region should be higher relative to the renal cortex and it may play an essential role in the control of medullary blood flow. Moreover, studies have indicated that medullary blood flow and renal interstitial hydrostatic pressure participate in the control of sodium and water excretion. Increases in medullary blood flow inhibit tubular transport and result in diuresis and natriuresis (9). The extent to which endogenous medullary adenosine contributes to the control of renal sodium and water excretion through its medullary hemodynamic effect is unknown.
The present studies were designed to determine and compare medullary and cortical interstitial adenosine concentrations using microdialysis and fluorescence HPLC techniques and to examine the role of endogenous medullary adenosine in the control of medullary blood flow and renal sodium and water excretion. A renal interstitial catheter was implanted to deliver adenosine and its receptor agonists or antagonists into the renal medullary interstitial space, and changes in regional blood flows were determined by laser-Doppler flowmetry.
| |
MATERIALS AND METHODS |
|---|
|
Top
Abstract
Introduction
Materials and methods
Results
Discussion
References
|
|---|
Surgical Preparation
Experiments were performed on male Sprague-Dawley rats weighing between 250 and 300 g. The rats were fed a normal salt diet (1% NaCl). Before experiments, rats was fasted overnight but allowed free access to water. They were anesthetized with ketamine (30 mg/kg body wt im) and Inactin (50 mg/kg body wt ip) and placed on a thermostatically controlled warming table to maintain body temperature at 37°C. After tracheotomy, cannulas were placed in the right femoral vein and artery for intravenous infusions and measurement of arterial pressure. An abdominal incision was made, and the left kidney was placed in a stainless steel cup for implantation of optical fibers to measure cortical and medullary blood flows or for implantation of microdialysis probes to dialyze adenosine from the renal interstitium. An interstitial catheter was implanted into the renal medulla for renal medullary interstitial infusion of drugs. After implantation, a 0.9% solution of sodium chloride was continuously infused at a rate of 0.5 ml/h to maintain the patency of the catheter (19). Ureters were cannulated for collection of urine. The animals received an intravenous infusion of 2% bovine serum albumin in a 0.9% sodium chloride solution, at a rate of 3 ml/h throughout the experiment to replace fluid losses and maintain a stable hematocrit of ~43 ± 3%.Experimental Protocols
Protocol 1: Microdialysis analysis of adenosine concentration in the renal cortex and medulla. In vivo microdialysis study was performed according to the technique described by Baranowski and Westenfelder (3). Briefly, the rats (n = 9) were anesthetized and surgically prepared as described above. The left kidney was exposed and immobilized by placing it dorsal side up in a kidney cup. A microdialysis probe (Bioanalytical Systems, West Lafayette, IN) with 0.5-mm tip diameter, 1-mm dialysis length, and a 20-kDa transmembrane diffusion cutoff was inserted into the renal cortex (1.5 mm in depth) horizontally from kidney pole and another was inserted into the renal medulla (5 mm in depth) from dorsal surface. The cortical probe was perfused at 2 µl/min with PBS (in mM: 80 NaCl, 40.5 Na2HPO4, and 9.5 NaH2PO4, pH 7.4 and osmolarity 300 mosM), and the medullary probe was perfused with PBS containing (in mM) 205 NaCl, 40.5 Na2HPO4, and 9.5 NaH2PO4 (pH 7.4 and osmolarity 550 mosM). The dialysate was collected for 30 min and then either reacted with fluorescence dye (chloroacetaldehyde) immediately or stored at
80°C until HPLC analysis.
Protocol 2: Effects of renal medullary interstitial
infusion of A1 and
A2 receptor antagonists on
medullary blood flow and renal function. These
experiments were performed in 22 rats to evaluate the role of
endogenous adenosine in the control of renal medullary blood flow. The
rats were anesthetized and surgically prepared as described above. The
left kidney was exposed and immobilized by placing it dorsal side up in
a kidney cup. Laser-Doppler flowmeters (model Pf3, PERIMED KB) were
used to simultaneously determine the changes in three regions of the
left kidney with one optical fiber (diameter of 500 µm) implanted in
the renal cortex, another in the outer medulla, and a third in the
inner medulla as described previously (19). The implanted fibers were
optically connected to an external probe specifically designed for such
applications (model Pf318A, PERIMED KB) using fused silica matching
liquid (#50350, Cargille Laboratories, Cedar Grove, NJ) to minimize
loss of light at the connection. The laser-Doppler signal, which is the
product of the number of moving particles and their velocity, is
thereby used as an index of changes of blood flow in the different portions of the kidney (19). After surgery and a 60-min equilibration period, continuous measurements of mean arterial pressure (MAP) and
cortical, outer, and inner medullary blood flows were obtained throughout the experiment. Saline was infused into the renal medullary interstitium for two 20-min control periods. At the end of the second
control period, either a selective
A1 antagonist,
8-cyclopentyl-1,3-dipropylxanthine (DPCPX)
(n = 8, 300 pmol · kg1 · min1),
or A2 antagonist,
3,7-dimethyl-1-propargylxanthine (DMPX)
(n = 9, 150 pmol · kg1 · min1),
was infused into the renal medullary interstitium for 30 min. Doses of
DPCPX and DMPX for renal medullary interstitial infusion were chosen on
the basis of those used in previous in vivo studies, at which DPCPX and
DMPX specifically blocked A1 and
A2 receptors, respectively (23,
27).
To determine whether endogenous medullary adenosine contributes to the
control of sodium and water excretion, we also examined the effects of
A1 and
A2 receptor antagonists on renal
function. Seventeen rats were surgically prepared as described above.
The animal received an intravenous infusion of 2% bovine serum albumin in 0.9% sodium chloride, and
[3H]inulin (1 µCi/ml) was added to the infusion solution for measurement of GFR.
After surgery and a 1-h equilibration period, urine flow, sodium
excretion, and GFR were measured in both left and right kidneys during
a 30-min control period. DPCPX was then infused through the renal
interstitial catheter into the renal medulla at a rate of 0.5 ml/h to
deliver a dose of 300 pmol · kg1 · min1
(n = 6), or DMPX was infused at a dose
of 150 pmol · kg1 · min1
(n = 11). Fifteen minutes after drug
infusions were started, urine and plasma samples were again collected
over a 30-min period from the left and right kidneys.
Protocol 3: Effects of renal medullary interstitial
infusion of adenosine on medullary blood flow and renal
function. Nineteen rats were anesthetized and
surgically prepared as described above to determine the effects of
renal medullary interstitial infusion of adenosine on medullary blood
flow. The left kidney was exposed and immobilized by placing it dorsal
side up in a kidney cup. After surgery and a 60-min equilibration
period, continuous measurements of MAP and laser-Doppler measurements
of cortical, outer, and inner medullary blood flow were obtained
throughout the experiment as described in
protocol
2. Saline was infused into the renal medullary interstitium for two 20-min control periods. At the end of
the second control period, adenosine was infused into the renal
medullary interstitium for 20 min at doses of 3, 30, and 300 pmol · kg1 · min1
(n = 7). Finally, the interstitial
infusion was switched back to saline for 30 min. To define the receptor
type responding to exogenous adenosine on medullary vessels, either
DPCPX (n = 6, 300 pmol · kg1 · min1)
or DMPX (n = 6, 150 pmol · kg1 · min1)
was infused into the renal medullary interstitial space before and
during adenosine infusion. Simultaneously, plasma and urine samples
from the left and right kidneys were collected to measure sodium and
water excretion during control and experimental periods as described
above. In time control experiments (n = 6), saline vehicle alone was infused into the renal medullary
interstitium during control and experimental periods.
Protocol 4: Effects of renal medullary interstitial
infusion of A3 receptor agonist
on medullary blood flow and renal function. Because a
specific A3 receptor antagonist is
not yet available, we examined the effect of a selective
A3 receptor agonist,
N6-benzyl-5'-(N-ethylcarbonxamido)adenosine
(N6-benzyl-NECA)
on renal medullary blood flow. Six rats were anesthetized and
surgically prepared as described above for continuous measurements of
MAP and laser-Doppler measurements of cortical, outer, and inner
medullary blood flows. Saline was infused into the renal medullary
interstitium for two 20-min control periods. At the end of the second
control period,
N6-benzyl-NECA
was infused into the renal medullary interstitium for 40 min at a dose
of 300 pmol · kg1 · min1
(n = 6) followed by a 30-min
interstitial infusion of saline. Plasma and urine samples from the left
and right kidneys were collected to measure sodium and water excretion
during control and experimental periods as described above. The dose of
N6-benzyl-NECA
was chosen on the basis of its A3
affinity analysis (Ki = 6.1 nM)
(31) and previous in vivo study (28).
HPLC Assay of Adenosine
HPLC assay of adenosine was performed as we described previously (24). The cortical and medullary dialysates (50 µl) were transferred into autosample vials and mixed with 4 µl of 1 M acetate buffer (pH 7.5) and 2 µl of 50% chloroacetaldehyde. The vials were capped and incubated at 60°C for 4 h. Reaction mixtures (5 µl) were injected and chromatographed on a 1090 Series II liquid chromatograph (Hewlett-Packard, Palo Alto, CA) using an autosampler and a column-switching valve. A shielded hydrophobic phase column, HiSep, 250 × 2.1 mm (Supelco, Bellefonte, PA) and an ODS-S C18, 250 × 2.0 mm (Metachem Technologies, Torrance, CA) with an isochratic mobile phase of 10% acetonitrile and 90% of 0.1 M sodium acetate and 0.002 M 1-octanesulfonic acid were used for separation. The flow rate was 0.2 ml/min. The eluate from the HiSep column was bypassed to waste 6 s after injection. After 5 min, the effluent was switched back to the C18 column for further separation and passed through the detector. The fluorescence was detected by an FS 970 LC Fluorometer (Kratos Analytical Instruments, Ramsey, NJ) with an excitation wavelength of 274 nm and a 370-nm loop-pass filter for emission. The chromatograph was recorded, and the peaks were integrated on a 3392 integrator (Hewlett-Packard). The run time was 20 min with 5 min post run (24). To determine derivatization reaction recovery, a known concentration of adenosine was reacted with chloroacetaldehyde as described above, and 1, N6-ethenoadenosine standard was serially diluted to construct the standard curve.Analytical Techniques
[3H]inulin concentrations of urine and plasma samples were determined using a liquid-scintillation counter (model 2450, Packard Instrument, Downers Grove, IL). Urine flow rate was determined gravimetrically. Sodium and potassium concentrations of urine and plasma samples were measured using a flame photometer. GFR was calculated as the product of urine flow and the urine-to-plasma inulin concentration ratio. Urinary excretion data, renal blood flow, and GFR were all factored per gram kidney weight.Statistics
Data are presented as means ± SE. The significance of differences within and between groups was evaluated using an ANOVA for repeated measures followed by a Duncan's multiple-range test and using a paired t-test. P < 0.05 was considered statistically significant.| |
RESULTS |
|---|
|
Top
Abstract
Introduction
Materials and methods
Results
Discussion
References
|
|---|
Protocol 1: Renal Interstitial Concentration of Adenosine in the Renal Medulla and Cortex
A typical reverse phase-HPLC chromatogram depicting the profile of the fluorescent derivatives of adenosine is presented in Fig. 1A. Adenosine (1 µM) was reacted with chloroacetaldehyde to form a fluorescence product, 1, N6-ethenoadenosine. This fluorescence product coeluted with synthetic 1, N6-ethenoadenosine standard with a retention time of 9 min. When the sample containing adenosine was incubated with adenosine deaminase (1 U), the 9-min peak disappeared (Fig. 1B). Adenosine concentrations of renal cortical and medullary dialysates are presented in Fig. 1C. Adenosine concentration in renal medullary interstitial dialysate averaged 212 ± 5.2 nM, which was significantly higher than 55.6 ± 5.3 nM in cortical dialysate.
|
Protocol 2: Effects of Renal Medullary Interstitial Infusion of A1 and A2 Receptor Antagonists on Medullary Blood Flow and Renal Function
The effects of renal medullary interstitial infusion of DPCPX and DMPX on cortical and medullary blood flows are presented in Fig. 2. In control periods, the laser-Doppler signals from the fibers implanted in the renal cortex and outer and inner medulla averaged 1.56 ± 0.2, 0.80 ± 0.12, and 0.51 ± 0.1 V, respectively. The cortical flow signal was not altered from control values during the renal medullary interstitial infusion of either the A1 or the A2 antagonist. Renal medullary interstitial infusion of the A2 antagonist DMPX significantly decreased outer and inner medullary flow signals by 28.5 and 27.5% compared with control flow signal, respectively. In contrast, infusion of the A1 antagonist DPCPX had no effect on flow signals in either of the medullary regions. MAP was not altered from the control level (115 ± 3 mmHg) during renal medullary interstitial infusion of the A1 and A2 antagonists.
|
The effects of renal medullary interstitial infusion of the
A1 and
A2 antagonists on renal function
are summarized in Table 1. GFR, urine flow
rate, and sodium and potassium excretion all were similar in the
infused and contralateral kidney during the control period, indicating
that implantation of an infusion catheter in the renal medulla and
renal medullary interstitial infusion of saline had no significant
effect on renal tubular or vascular function. Renal medullary
interstitial infusion of the A1
antagonist DPCPX produced an increase in urine flow rate and sodium
excretion of 28.3 and 29.7%, respectively, in the absence of changes
in GFR. Urine flow rate, sodium excretion, and GFR in the contralateral control kidney were not significantly altered during these experiments, indicating that medullary interstitial infusion of DPCPX was localized in the infused kidney. In contrast, renal medullary interstitial infusion of the A2 receptor
antagonist DMPX reduced urine flow rate and sodium excretion by 24.3 and 25.7%, respectively, without changes in GFR. In the contralateral
control kidney, urine flow rate, sodium excretion, and GFR were not
significantly altered during these experiments. MAP remained unchanged
throughout all of the above studies.
|
Protocol 3: Effects of Renal Medullary Interstitial Infusion of Adenosine on Medullary Blood Flow and Renal Function
Renal medullary interstitial infusion of adenosine produced a concentration-dependent increase in medullary blood flows. As shown in Fig. 3, adenosine infusion at a dose of 300 pmol · kg1 · min1
had no effect on cortical flow signal but significantly increased outer
and inner medullary flow signals by 30 and 25%, respectively. Both
outer and inner medullary blood flows returned to levels not
significantly different from control during a 20-min postcontrol period. Vehicle infusion had no effect on cortical and medullary blood
flows.
|
Figure 4 presents the effects of renal
medullary interstitial infusion of adenosine on sodium and water
excretion. A concentration-dependent increase in urine flow rate and
sodium excretion was observed during renal medullary interstitial
infusion of adenosine. Infusion of adenosine even at the highest doses
studied (300 pmol · kg1 · min1)
did not alter sodium and water excretion in the contralateral kidney.
During the postcontrol period, urine flow rate and sodium excretion
returned to control levels.
|
The effects of A1 and
A2 receptor blockade on
adenosine-induced changes in renal regional blood flows and sodium
excretion are depicted in Fig. 5. Renal
medullary interstitial infusion of adenosine at a dose of 300 pmol · kg1 · min1
increased outer medullary flow signal by 0.23 V (29%) and inner medullary flow signal by 0.13 V (25%) and had no effect on the cortical flow signal. Adenosine infusion also significantly increased urine flow rate and sodium excretion. Blockade of
A1 receptor by DPCPX had no effect
on baseline renal blood flows, but increased water excretion from 12.8 ± 1.9 to 21.3 ± 2.8 µl · min1 · g
kidney wt1 and sodium
excretion from 1.43 ± 0.28 to 2.73 ± 0.36 µmol · min1 · g
kidney wt1. However, DPCPX
did not alter adenosine-induced increase in outer and inner medullary
blood flows and in sodium and water excretion. In contrast, blockade of
A2 receptor by DMPX not only
decreased baseline medullary blood flows (outer from 0.82 ± 0.09 to
0.65 ± 0.07 V and inner from 0.45 ± 0.04 to 0.34 ± 0.03 V)
but also abolished the increase in medullary blood flows during
medullary interstitial infusion of adenosine. DMPX also significantly
attenuated the adenosine-induced increase in water and sodium
excretion. MAP remained unchanged throughout all of the above studies.
|
Protocol 4: Effects of Renal Medullary Interstitial Infusion of A3 Receptor Agonist on Medullary Blood Flow and Renal Function
A3 receptor agonist N6-benzyl-NECA produced significant decrease in MAP when infused intravenously at a dose of 300 pmol · kg1 · min1
(data not shown). Renal medullary interstitial infusion of
N6-benzyl-NECA at
the same dose had no effect on cortical and medullary flow signals,
renal function, or MAP (Table 2).
|
| |
DISCUSSION |
|---|
|
Top
Abstract
Introduction
Materials and methods
Results
Discussion
References
|
|---|
Recent studies have indicated that the effects of adenosine on renal function depend on its concentration in the extracellular space (2, 26). In the present studies, we evaluated adenosine concentrations in renal medullary interstitial dialysate by microdialysis and fluorescence HPLC analysis. We have found that adenosine concentrations in interstitial dialysate were significantly higher in the renal medulla than in the cortex. Our results are consistent with those by Siragy and Linden (33), who reported that adenosine concentration in renal medullary dialysate from rats on normal salt diet (0.28% NaCl) was 157 ± 6 nM, which is significantly higher than 63 ± 6 nM in renal cortical dialysate. However, cortical adenosine concentration detected in the present study is much lower compared with the value (199 ± 53 nM) reported by Baranowski and Westenfelder (3). The reason for this discrepancy may be due to the different length of dialysis tubing in our probes (1 mm in length) from theirs (2 mm). The probe with a long dialysis tubing may dialyze adenosine from the deeper cortical area close to renal medulla if inserted from the dorsal surface as carried out by Baranowski and Westenfelder (3). For dialysis of cortical adenosine, we inserted the probe from the kidney pole into the renal cortex ~1.5 mm from the outer renal surface, which was similar to the method used by Siragy and Linden (33). Therefore, cortical adenosine concentration detected in the present study represents a concentration in the outer renal cortex.
Although the present study did not examine the mechanism leading to high concentration of renal medullary interstitial adenosine, a high metabolic activity and limited oxygen supply in the renal outer medulla may increase the production of adenosine in this region. Recent studies have demonstrated that the medullary TALH releases adenosine in response to hypoxia (11). Under control conditions, PO2 in the renal medulla has been found to be <20 mmHg (10, 11, 20). Therefore, a low intracellular PO2 and high transport activity in the medullary TALH may result in enhanced production and release of adenosine in this kidney region (8, 11).
The role of adenosine in the control of the medullary oxygenation and
the protection of the cells of medullary TALH from hypoxic damage has
been extensively examined (11, 12). In the isolated perfused kidney,
addition of adenosine deaminase or an adenosine efflux inhibitor
6-nitrobenzylthionosine to the perfusate resulted in exaggerated
hypoxic damage to the cells of medullary thick ascending limb (12).
This suggests that endogenous interstitial adenosine may play an
important role in protecting medullary thick ascending limb from
hypoxic injury. In the same preparation, an adenosine analog,
R()-phenylisopropyladenosine,
markedly reduced hypoxic injury to these cells when added to the
perfusate (12). The protecting effect of adenosine has been proposed to
be associated with the medullary oxygenation because renal interstitial
infusion of adenosine significantly increased medullary
PO2 (10) and medullary blood flow
(1), indicating that increase in medullary adenosine is of substantial
importance in protecting medullary tubular cells from hypoxic injury
through an increase in medullary blood flow and medullary oxygen supply.
Despite these observations, there has been no direct evidence suggesting that endogenously produced adenosine in the renal medulla participates in the regulation of medullary blood flow and hence medullary oxygenation under physiological conditions. In the present studies, we examined the role of endogenous medullary adenosine in the control of medullary blood flow by infusing specific adenosine receptor antagonists into the renal medullary interstitial space while measuring changes in blood flow to this region. Infusion of the A2 receptor antagonist DMPX into the renal medullary interstitial space markedly decreased blood flow in both the outer and inner medulla of the anesthetized rats. In contrast, infusion of the A1 receptor antagonist DPCPX had no effect on medullary blood flows. These results indicate that endogenous medullary adenosine contributes importantly to medullary vascular tone via A2 receptors. Conversely, elevations of medullary adenosine concentrations by administration of adenosine into medullary interstitial space increased medullary blood flow. These findings demonstrate that medullary adenosine exerts vasodilator effect under normal conditions and during states of elevated adenosine.
However, Silldorf et al. (32) observed that adenosine at
1012-107
M produced vasoconstriction of isolated perfused outer medullary descending vasa recta, but by A1
receptor activation. In the present study, we did not observe
A1 receptor-mediated
vasoconstrictor effects on medullary vessels in the intact
blood-perfused kidney, although the
A1 receptor blocker DPCPX was
infused into the renal medullary interstitial space at a dose
sufficient to alter tubular function. Our data are consistent with
previous reports suggesting that interstitial infusion of
A1 receptor agonists had no effect on medullary blood flow and oxygenation (1). The effects of A1 receptor blockade or activation
on medullary vessels in vivo may be related to a high basal
concentration of adenosine in the renal medullary interstitium, which
could mask vasoconstrictor actions of
A1 receptors by predominately
stimulating A2 receptors. Indeed,
a vasodilator effect with high concentration of adenosine (106-105
M) was also observed in the in vitro isolated and perfused vasa recta
(32).
Recent studies in our laboratory and others showed that medullary blood flow plays an important role in the control of renal sodium and water excretion (13). It has been also reported that infusion of adenosine into the renal artery, at doses that did not activate systemic receptor sites, produced marked natriuresis and diuresis in rats (22, 37). The mechanism by which intrarenal adenosine produced natriuresis remains unknown. In the present study, we determined whether elevation of medullary adenosine contributed to the control of renal sodium and water excretion by increasing medullary blood flow. We found that renal medullary interstitial infusion of the selective A2 receptor antagonist that reduced medullary blood flow significantly decreased sodium and water excretion in anesthetized rats. These observations indicate that adenosine contributes to the normal maintenance of sodium and water excretion via A2 receptor stimulation under physiological conditions. In contrast, renal medullary infusion of specific A1 receptor blocker increased sodium and water excretion. Because A1 receptor blockade had no effect on medullary blood flow, we propose that this A1 receptor-mediated antinatriuretic and antidiuretic effect may be due to a direct effect on medullary tubular transport. Taken together, the results suggest that medullary adenosine could contribute importantly to the control of sodium and water excretion largely through the vascular effects.
Our findings are not consistent with conclusions reached by others with exogenously infused adenosine, which reduced chloride reabsorption in the loop of Henle and sodium reabsorption in the inner medullary collecting duct (4, 29). The reason for this discrepancy is not apparent, but it is possible that adenosine at physiological concentrations has direct stimulatory effects on tubular transport mediated by A1 receptors. A recent study by Ling et al. (18) using A6 distal nephron cells and patch-clamp technique supports this view. They found that adenosine at physiological concentrations (nanomolar range) increased the activity of amiloride-sensitive Na+ channels on the apical membrane, and increases in adenosine concentration to micromolar range inhibited the activity of these Na+ channels. The A1 receptor antagonist DPCPX blocked the stimulatory effect of low concentrations of adenosine on the Na+ channel activity, and the A2 receptor antagonist DMPX blocked the inhibitory effects of high concentrations of adenosine on the Na+ channel activity.
Recently, the molecular and pharmacological characteristics of a novel adenosine receptor subtype designated A3 were described (38). It was shown that activation of A3 receptors produced hypotension, mast cell degranulation, and vasoconstriction (17, 30). A3 receptor-mediated adenosine effects on renal medullary blood flow and renal function have not been previously studied. In the present study, we found that renal medullary infusion of benzyl-NECA, a specific A3 receptor agonist, had no effect on either medullary blood flow or sodium and water excretion, even at a dose that decreased arterial blood pressure when infused intravenously. Therefore, it appears that A3 receptors do not participate in the control of medullary blood flow and sodium and water excretion.
In summary, the present data provide evidence that high concentrations of adenosine are present in the renal medullary interstitial dialysate. Endogenous adenosine dilates medullary vessels and increases medullary blood flow via A2 receptors, resulting in a natriuretic response. This A2 receptor-mediated effect of adenosine on renal medullary hemodynamics overrides A1 receptor-mediated tubular antinatriuretic effects and hence plays an important role in the control of renal sodium and water excretion. A3 receptors do not participate in the effect of adenosine on medullary circulation and sodium and water excretion.
Perspectives
Our previous studies have demonstrated that medullary blood flow was poorly autoregulated and rise of renal perfusion pressure increases medullary blood flow, which provides a signal that transmits increases in arterial pressure to the tubules to enhance sodium and water excretion. It will be intriguing to determine whether a high concentration of medullary adenosine and its vasodilator effect shown in the present study contribute to the poor autoregulation of medullary blood flow and pressure natriuretic response. Moreover, because medullary blood flow participates in the long-term control of arterial blood pressure (9), adenosine as an endogenous vasodilator in the renal medullary circulation would be expected to be a medullary antihypertensive factor.| |
ACKNOWLEDGEMENTS |
|---|
This study was supported by National Institutes of Health Grants HL-29587 and DK-52112 and a National Kidney Foundation Young Investigator grant.
| |
FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: A.-P. Zou, Dept. of Physiology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226 (E-mail azou{at}post.its.mcw.edu).
Received 25 August 1998; accepted in final form 4 December 1998.
| |
REFERENCES |
|---|
|
Top
Abstract
Introduction
Materials and methods
Results
Discussion
References
|
|---|
1.
Agmon, Y.,
D. Dinour,
and
M. Brezis.
Disparate effects of adenosine A1- and A2-receptor agonists on intrarenal blood flow.
Am. J. Physiol.
265 (Renal Fluid Electrolyte Physiol. 34):
F802-F806,
1993
2.
Arend, L. J.,
W. S. Sonnenberg,
W. L. Smith,
and
W. S. Spielman.
A1 and A2 adenosine receptors in rabbit cortical collecting tubule cells.
J. Clin. Invest.
79:
710-714,
1987.
3.
Baranowski, R. L.,
and
C. Westenfelder.
Estimation of renal interstitial adenosine and purine metabolites by microdialysis.
Am. J. Physiol.
267 (Renal Fluid Electrolyte Physiol. 36):
F174-F182,
1994
4.
Beach, R. E.,
and
D. W. Good.
Effects of adenosine on ion transport in rat medullary thick ascending limb.
Am. J. Physiol.
263 (Renal Fluid Electrolyte Physiol. 32):
F482-F487,
1992
5.
Berne, R. M.
Cardiac nucleotides in hypoxia: possible role in regulation of coronary blood flow.
Am. J. Physiol.
204:
317-322,
1963.
6.
Biaggioni, I.,
and
R. Mosqueda-Garcia.
Adenosine in cardiovascular homeostasis and the pharmacologic control of its activity.
In: Hypertension: Pathophysiology, Diagnosis, and Management (2nd ed.). New York: Raven, 1995, p. 1125-1140.
7.
Blanco, J.,
E. I. Canela,
J. Mallol,
C. Lluis,
and
R. Franco.
Characterization of adenosine receptors in brush-border membrane from pig kidney.
Br. J. Pharmacol.
7:
671-678,
1992.
8.
Brezis, M.,
S. Rosen,
and
F. H. Epstein.
The pathophysiological implications of medullary hypoxia.
Am. J. Kidney Dis.
13:
253-258,
1989[Medline].
9.
Cowley, A. W., Jr.
Long-term control of arterial blood pressure.
Physiol. Rev.
72:
231-300,
1992
10.
Dinour, D.,
and
M. Brezis.
Effects of adenosine on intrarenal oxygenation.
Am. J. Physiol.
261 (Renal Fluid Electrolyte Physiol. 30):
F787-F791,
1991
11.
Epstein, F. H.
Oxygen and renal metabolism.
Kidney Int.
51:
381-385,
1997[Medline].
12.
Epstein, F. H.,
S. Rosen,
G. Galicka-Piskorska,
K. Spokes,
M. Brezis,
and
P. Silva.
Relation of adenosine to medullary injury in the perfused rat kidney.
Miner. Electrolyte Metab.
16:
185-190,
1990[Medline].
13.
Freissmuth, M.,
V. Hausleithner,
E. Tuisel,
C. Nanoff,
and
W. Schutz.
Glomeruli and microvessels of the rabbit kidney contain both A1- and A2-adenosine receptors.
Naunyn Schmiedebergs Arch. Pharmacol.
335:
438-444,
1987[Medline].
14.
Haddy, F. J.,
and
J. B. Scott.
Metabolically linked vasoactive chemicals in local regulation of blood flow.
Physiol. Rev.
48:
688-707,
1968
15.
Kreisberg, M. S.,
E. P. Silldorf,
and
T. L. Pallone.
Localization of adenosine-receptor subtype mRNA in rat outer medullary descending vasa recta by RT-PCR.
Am. J. Physiol.
272 (Heart Circ. Physiol. 41):
H1231-H1238,
1997
16.
Kriz, W.,
and
B. Kaissling.
Structural organization of the mammalian kidney.
In: The Kidney: Physiology and Pathophysiology (2nd ed.), edited by D. W. Seldin,
and G. Giebish. New York: Raven, 1992, p. 707-777.
17.
Linden, J.
Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions.
Trends Pharmacol. Sci.
15:
298-306,
1994[Medline].
18.
Ling, B. N.,
H. Ma,
and
D. C. Eaten.
Luminal adenosine receptors regulate amiloride-sensitive Na+ channels in A6 distal nephron cells.
Am. J. Physiol.
270 (Renal Fluid Electrolyte Physiol. 39):
F798-F805,
1996
19.
Lu, S.-H.,
R. J. Roman,
D. L. Mattson,
and
A. W. Cowley, Jr.
Renal medullary interstitial infusion of diltiazem alters sodium and water excretion in rats.
Am. J. Physiol.
263 (Regulatory Integrative Comp. Physiol. 32):
R1064-R1070,
1992
20.
Luebbers, D. W.,
and
H. Baumgaertal.
Heterogeneities and profiles of oxygen pressure in brain and kidney as examples of the PO2 distribution in the living tissue.
Kidney Int.
51:
372-380,
1997[Medline].
21.
McCoy, D. E.,
B. Samita,
B. A. Olson,
D. G. Levier,
L. J. Arend,
and
W. S. Spielman.
The renal adenosine system: structure, function and regulation.
Semin. Nephrol.
13:
31-40,
1993[Medline].
22.
Miyamoto, M.,
Y. Yagil,
T. Larson,
C. Robertson,
and
R. L. Jamison.
The effect of intrarenal adenosine on renal excretory function and medullary blood flow in the rat.
Am. J. Physiol.
255 (Renal Fluid Electrolyte Physiol. 24):
F1230-F1234,
1988
23.
Nehlig, A.,
J. L. Daval,
and
S. Boyet.
Effects of selective adenosine A1 and A2 receptor agonists and antagonists on local rates of energy metabolism in the rat brain.
Eur. J. Pharmacol.
258:
57-66,
1994[Medline].
24.
Nithipatikom, K.,
T. Mizumura,
and
G. J. Gross.
Determination of plasma adenosine by high-performance liquid chromatography with column switching and fluorometric detection.
Anal. Biochem.
223:
280-284,
1994[Medline].
25.
Olah, M.,
and
G. L. Stile.
Adenosine receptor subtypes: characterization and therapeutic regulation.
Annu. Rev. Pharmacol. Toxicol.
35:
581-605,
1995[Medline].
26.
Pawlowska, D. J.,
J. P. Granger,
and
F. G. Knox.
Effects of adenosine infusion into renal interstitium on renal hemodynamics.
Am. J. Physiol.
252 (Renal Fluid Electrolyte Physiol. 21):
F678-F682,
1987
27.
Pflüger, A. C.,
T. J. Berndt,
and
F. G. Knox.
Effect of renal interstitial adenosine infusion on phosphate excretion in diabetes mellitus rats.
Am. J. Physiol.
274 (Regulatory Integrative Comp. Physiol. 43):
R1228-R1235,
1998
28.
Sawyanok, J.,
M. R. Zarrindast,
A. R. Reid,
and
G. J. Doak.
Adenosine A3 receptor activation produces nociceptive behaviour and edema by release of histamine and 5-hydroxytryptamine.
Eur. J. Pharmacol.
333:
1-7,
1997[Medline].
29.
Seney, F. D., Jr.,
and
M. G. Seikaly.
Adenosine inhibits sodium uptake in the loop of Henle (Abstract).
Clin. Res.
37:
501A,
1989.
30.
Shepherd, R. K.,
J. Linden,
and
B. R. Duling.
Adenosine-induced vasoconstriction in vivo. Role of the mast cell and A3 adenosine receptor.
Circ. Res.
78:
627-634,
1996
31.
Siddiqi, S. M.,
R. A. Pearlstein,
L. H. Sanders,
and
K. A. Jacobson.
Comparative molecular field analysis of selective A3 adenosine receptor agonist.
Bioorg. Med. Chem.
3:
1331-1343,
1995[Medline].
32.
Silldorf, E. P.,
M. S. Kreisberg,
and
T. L. Pallone.
Adenosine modulates vasomotor tone in outer medullary descending vasa recta of the rat.
J. Clin. Invest.
98:
18-23,
1996[Medline].
33.
Siragy, H. M.,
and
J. Linden.
Sodium intake markedly alters renal interstitial fluid adenosine.
Hypertension
27:
404-407,
1996
34.
Spielman, W. S.,
and
L. J. Arend.
Adenosine receptors and signaling in the kidney.
Hypertension
17:
117-130,
1991
35.
Weaver, D. R.,
and
S. M. Repper.
Adenosine receptor gene expression in the rat kidney.
Am. J. Physiol.
263 (Renal Fluid Electrolyte Physiol. 32):
F991-F995,
1992
36.
Woodcock, E. A.,
E. Leung,
and
C. I. Johnston.
Adenosine receptors in papilla of human kidneys.
Clin. Sci. (Colch.)
70:
353-357,
1986[Medline].
37.
Yagil, Y.
The effect of adenosine on water and sodium excretion.
J. Pharmacol. Exp. Ther.
268:
826-835,
1994
38.
Zhou, Q. Y.,
C. Li,
M. E. Olah,
R. A. Johnson,
G. L. Stiles,
and
O. Civelli.
Molecular cloning and characterization of adenosine receptor: the A3 adenosine receptor.
Proc. Natl. Acad. Sci. USA
89:
7432-7436,
1992
This article has been cited by other articles:
|
|
 |
|
  E. L. Liclican, J. C. McGiff, J. R. Falck, and M. A. Carroll Failure to upregulate the adenosine2A receptor-epoxyeicosatrienoic acid pathway contributes to the development of hypertension in Dahl salt-sensitive rats Am J Physiol Renal Physiol, December 1, 2008; 295(6): F1696 - F1704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Castrop Modulation of adenosine receptor expression in the proximal tubule: a novel adaptive mechanism to regulate renal salt and water metabolism Am J Physiol Renal Physiol, July 1, 2008; 295(1): F35 - F36. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Li, L. Chen, F. Yi, M. Xia, and P.-L. Li Salt-Sensitive Hypertension Induced by Decoy of Transcription Factor Hypoxia-Inducible Factor-1{alpha} in the Renal Medulla Circ. Res., May 9, 2008; 102(9): 1101 - 1108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Franco, R. Bautista, O. Perez-Mendez, L. Gonzalez, U. Pacheco, L. G. Sanchez-Lozada, J. Santamaria, E. Tapia, R. Monreal, and F. Martinez Renal interstitial adenosine is increased in angiotensin II-induced hypertensive rats Am J Physiol Renal Physiol, January 1, 2008; 294(1): F84 - F92. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Vallon, B. Muhlbauer, and H. Osswald Adenosine and kidney function. Physiol Rev, July 1, 2006; 86(3): 901 - 940. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Neuhofer and F.-X. Beck Survival in Hostile Environments: Strategies of Renal Medullary Cells Physiology, June 1, 2006; 21(3): 171 - 180. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Liclican, J. C. McGiff, P. L. Pedraza, N. R. Ferreri, J. R. Falck, and M. A. Carroll Exaggerated response to adenosine in kidneys from high salt-fed rats: role of epoxyeicosatrienoic acids Am J Physiol Renal Physiol, August 1, 2005; 289(2): F386 - F392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. B. Hansen and J. Schnermann Vasoconstrictor and vasodilator effects of adenosine in the kidney Am J Physiol Renal Physiol, October 1, 2003; 285(4): F590 - F599. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-F. Chen, A. W. Cowley Jr., and A.-P. Zou Increased H2O2 counteracts the vasodilator and natriuretic effects of superoxide dismutation by tempol in renal medulla Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2003; 285(4): R827 - R833. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. W. Inscho Modulation of renal microvascular function by adenosine Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2003; 285(1): R23 - R25. [Full Text] [PDF]
|
|
|
|
|
|
T. L. Pallone, Z. Zhang, and K. Rhinehart Physiology of the renal medullary microcirculation Am J Physiol Renal Physiol, February 1, 2003; 284(2): F253 - F266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Mattson Importance of the renal medullary circulation in the control of sodium excretion and blood pressure Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2003; 284(1): R13 - R27. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. K. Jackson, C. Zhu, and S. P. Tofovic Expression of adenosine receptors in the preglomerular microcirculation Am J Physiol Renal Physiol, July 1, 2002; 283(1): F41 - F51. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-F. Chen, P.-L. Li, and A.-P. Zou Oxidative stress enhances the production and actions of adenosine in the kidney Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2001; 281(6): R1808 - R1816. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. B. Persson Tubuloglomerular feedback in adenosine A1 receptor-deficient mice Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2001; 281(5): R1361 - R1361. [Full Text] [PDF]
|
|
|
|
|
|
E. K. Jackson and R. K. Dubey Role of the extracellular cAMP-adenosine pathway in renal physiology Am J Physiol Renal Physiol, October 1, 2001; 281(4): F597 - F612. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-P. ZOU, Z.-Z. YANG, P.-L. LI, and A. W. COWLEY JR. Oxygen-dependent expression of hypoxia-inducible factor-1{alpha} in renal medullary cells of rats Physiol Genomics, August 28, 2001; 6(3): 159 - 168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Nishiyama, S. Kimura, H. He, K. Miura, M. Rahman, Y. Fujisawa, T. Fukui, and Y. Abe Renal interstitial adenosine metabolism during ischemia in dogs Am J Physiol Renal Physiol, February 1, 2001; 280(2): F231 - F238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Koos and T. Maeda Adenosine A2A receptors mediate cardiovascular responses to hypoxia in fetal sheep Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H83 - H89. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. K. Kost Jr., W. A. Herzer, B. R. Rominski, Z. Mi, and E. K. Jackson Diuretic Response to Adenosine A1 Receptor Blockade in Normotensive and Spontaneously Hypertensive Rats: Role of Pertussis Toxin-Sensitive G-Proteins J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 752 - 760. [Abstract] [Full Text]
|
|
|
|
|
|
B. T. Andresen, D. G. Gillespie, Z. Mi, R. K. Dubey, and E. K. Jackson Role of Adenosine A1 Receptors in Modulating Extracellular Adenosine Levels J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 76 - 80. [Abstract] [Full Text]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
